Convenient dosing that fits your patient's schedule1*
For adult and pediatric patients with moderate to severe plaque psoriasis (PsO)
Just one UnoReady® Pen per dose
Suggested prescribing approach1
For adults patients with moderate to severe PsO with or without PsA:
1 prescription for
loading doses
(Weeks 0, 1, 2, and 3)
For some patients, a loading and maintenance dose of
150 mg may be acceptable.
1 prescription for maintenance dose
Covers Week 4 loading dose as well as maintenance dose.
†If using the Sensoready Pen, your patients will need 2 pens for each dose.
Suggested prescribing approach1
For pediatric patients age 6 years and older with moderate to severe PsO:
1 prescription for loading doses
(Weeks 0, 1, 2, and 3)
The recommended dosage for pediatric patients age 6 years and older are based on body weight at time of dosing.
- For patients weighing <50 kg (<110 lb) the dose is 75 mg
- For patients weighing ≥50 kg (≥110 lb) the dose is 150 mg
1 prescription for maintenance dose
Covers Week 4 loading dose as well as maintenance dose.
COSENTYX must be prepared and injected at home by an adult caregiver after proper training in subcutaneous injection1
Pediatric patients should not self-administer COSENTYX using the prefilled syringe or the Sensoready® pen. An adult caregiver should prepare and inject COSENTYX after proper training in subcutaneous injection technique using the prefilled syringe or the Sensoready® pen.1
The removable caps of the COSENTYX Sensoready Pen and the COSENTYX 1-mL and 0.5-mL prefilled syringes contain natural rubber latex and should not be handled by latex-sensitive individuals. The safe use of the COSENTYX Sensoready Pen or prefilled syringes in latex-sensitive individuals has not been studied.1
Definitions
ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification; PsA, psoriatic arthritis; PsO, plaque psoriasis.
References
1. Cosentyx. Prescribing information. Novartis Pharmaceuticals Corp.